Evolution of resistance and progression to disease during clonal expansion of cancer

From MaRDI portal
Publication:1628721

DOI10.1016/j.tpb.2009.10.008zbMath1403.92171OpenAlexW2018106070WikidataQ51777419 ScholiaQ51777419MaRDI QIDQ1628721

Stephen Moseley, Richard T. Durrett

Publication date: 5 December 2018

Published in: Theoretical Population Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.tpb.2009.10.008




Related Items (21)

Evolutionary shift dynamics on a cycleEvolutionary dynamics of tumor progression with random fitness valuesMutation frequencies in a birth-death branching processBirth and death processes with neutral mutationsExponentiality of first passage times of continuous time Markov chainsA comparison of mutation and amplification-driven resistance mechanisms and their impacts on tumor recurrenceWaiting times in a branching process model of colorectal cancer initiationProgression, detection and remission: evolution of chronic myeloid leukemia using a three-stage probabilistic modelMutation timing in a spatial model of evolutionA spatial mutation model with increasing mutation ratesPopulation genetics of neutral mutations in exponentially growing cancer cell populationsStochastic Modelling of Multiple Random Genetic Mutations Under the Cancer Stem Cell HypothesisExact solution of a two-type branching process: clone size distribution in cell division kineticsMutant number distribution in an exponentially growing populationUniversal asymptotic clone size distribution for general population growthMutation in populations governed by a Galton-Watson branching processA branching process model of ovarian cancerSplitting trees with neutral mutations at birthOn mutations in the branching model for multitype populationsAn Evolutionary Model of Tumor Cell Kinetics and the Emergence of Molecular Heterogeneity Driving Gompertzian GrowthSplitting trees with neutral Poissonian mutations. I: Small families



Cites Work


This page was built for publication: Evolution of resistance and progression to disease during clonal expansion of cancer